Serological Cancer Markers
The purpose of this book-the fourth volume of a series on Can cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can cer, with an emphasis on cancer markers detected in the serum. It has been 7 years sinc...
Other Authors: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Totowa, NJ
Humana
1992, 1992
|
Edition: | 1st ed. 1992 |
Series: | Contemporary Biomedicine
|
Subjects: | |
Online Access: | |
Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- CH. 1. Cancer Markers of the 1990s: An Introduction
- CH. 2 Clinical Cancer Markers: Diagnosis Prognosis and Monitoring
- CH. 3 Alpha-Fetoprotein in the 1990s
- Ch. 4. Carcinoembryonic Antigen
- CH. 5. Prostate-Specific Antigen
- CH. 6. Enzyme Markers
- CH. 7. Alkaline Phosphatases as Tumor Markers
- CH. 8. Sex-Associated Hormones
- CH. 9. Tissue Polypeptide Antigen and Specific TPA
- CH. 10. Tumor-Associated Carbohydrate Markers: Chemical and Physical Basis and Cell Biological Implications
- CH. 11. Glycoamines:Structural-Functional Characterization of a New Class of Human Tumor Markers
- CH. 12. CA 15-3 Assay for the Detection of Episialin: A Serum Marker for Breast Cancer
- CH. 13. Clinical Applications of CA 15–3
- CH. 14. CA 19–9, GICA (Gastrointestinal Cancer Antigen)
- CH. 15. Mucin-Like Cancer-Associated Antigen (MCA) as Available Circulating Tumor Marker for Breast Cancer
- CH. 16. DU-PAN-2:A Clinically Useful Mucin Marker of Differentiation of Pancreatic and Other Ductal Cells and Their Tumors
- Ch. 17. CA 50
- Ch. 18. TAG-72 as a Tumor Marker
- Ch. 19. CA 125
- Ch. 20. CA 242
- Ch. 21. Squamous Cell Carcinoma Antigen
- Ch. 22. Tumor-Marker Detection by Isotachophoresis in Porous Membranes:Bence-Jones Protein in Chronic Lymphocytic and Non-Hodgkin’s Lymphoma
- Ch. 23. Multiple Testing with Cancer Markers
- Ch. 24. New Cancer Products: Predicting Market Success
- Ch. 25. Comments